Remdesivir and dexamethasone as tools to relieve hospital care systems stressed by COVID-19: A modelling study on bed resources and budget impact

Remdesivir and dexamethasone are the only drugs providing reductions in the lengths of hospital stays for COVID-19 patients. We assessed the impacts of remdesivir on hospital-bed resources and budgets affected by the COVID-19 outbreak. A stochastic agent-based model was combined with epidemiological...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	PloS one 2022-01, Vol.17 (1), p.e0262462
Hauptverfasser:	Béraud, Guillaume, Timsit, Jean-François, Leleu, Henri
Format:	Artikel
Sprache:	eng
Schlagworte:	Adenosine Monophosphate - analogs & derivatives Adenosine Monophosphate - economics Adenosine Monophosphate - therapeutic use Alanine - analogs & derivatives Alanine - economics Alanine - therapeutic use Antiviral Agents - economics Antiviral Agents - therapeutic use Antiviral drugs Bed Occupancy - economics Bed Occupancy - statistics & numerical data Budgets Clinical trials Complications and side effects Computer and Information Sciences Coronaviruses COVID-19 COVID-19 - economics COVID-19 - virology COVID-19 Drug Treatment Curfews Dexamethasone Dexamethasone - economics Dexamethasone - therapeutic use Epidemiology France Health care access Health risks Hospitalization Hospitalization - economics Hospitalization - statistics & numerical data Hospitals Humans Infections Infectious diseases Intensive care Intensive Care Units Length of Stay Medicine and Health Sciences Models, Statistical Occupancy Outbreaks Oxygen Pandemics Patient outcomes Patients People and places Pharmaceuticals Physical Sciences Population Probability Public health Research and Analysis Methods SARS-CoV-2 - isolation & purification Severe acute respiratory syndrome coronavirus 2 Steroids Stochasticity Ventilators
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!